{"id":4906,"date":"2019-10-09T17:01:54","date_gmt":"2019-10-09T15:01:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/asia-pacific-self-monitoring-blood-glucose-devices-market-2019-2024-share-scope-revenue-growth-forecast-trends-drivers-challenges-researchandmarkets-com\/"},"modified":"2019-10-09T17:01:54","modified_gmt":"2019-10-09T15:01:54","slug":"asia-pacific-self-monitoring-blood-glucose-devices-market-2019-2024-share-scope-revenue-growth-forecast-trends-drivers-challenges-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/asia-pacific-self-monitoring-blood-glucose-devices-market-2019-2024-share-scope-revenue-growth-forecast-trends-drivers-challenges-researchandmarkets-com\/","title":{"rendered":"Asia-Pacific Self-Monitoring Blood Glucose Devices Market (2019-2024): Share, Scope, Revenue, Growth Forecast, Trends, Drivers, Challenges – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Asia-Pacific Self-Monitoring Blood Glucose Devices Market (2019-2024) Share, Scope, Revenue, Growth Forecast, Trends, Drivers, Challenges, Segmentation based on Product Type (Testing Strips, Glucometers, Others) End-User Type and Countries”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe Asia-Pacific self-monitoring blood glucose devices market is expected to expand at a CAGR of 6.34% during the 2019-2024 period, owing to technological breakthroughs, rising obesity, and the increasing prevalence of diabetes.\n<\/p>\n

\nProduct Segment Insights <\/strong>\n<\/p>\n

\nThe testing strips segment is expected to hold the highest market share (81.64%) in 2019. Owing to the development of innovative testing strips, and a massive increase in the incidence of diabetes, this segment is expected to witness a high CAGR of 6.94% during the forecast period. The glucometers segment is expected to remain steady while generating 12% of the revenue in the Asia-Pacific market in 2019. Factors like the advantages of glucometers over regular monitoring methodologies and the production of a wide range of devices will drive this segment. However, variations in results due to external and physiological factors will lead to a comparatively low CAGR (4.95%) during the 2019-2024 period.\n<\/p>\n

\nEnd-user Segment Insights <\/strong>\n<\/p>\n

\nThe shift of medical services to decentralized surroundings like patients’ homes and the development of portable and user-friendly blood glucose monitoring devices will enable the home settings segment to expand at a CAGR of 6.82% during the 2019-2024 period. The hospital’s sector will generate almost 7% of the total market revenue by 2019 and is anticipated to expand at a CAGR of 4.78% during the forecast period.\n<\/p>\n

\nCountry-wise Insights <\/strong>\n<\/p>\n

\nChina and India account for half of the total diabetic population in the Asia-Pacific region. Advanced medical facilities, awareness programs, and cost-effective treatments to tackle diabetes will transform this region into the fastest-growing SMBG devices market in the world. China is expected to expand at a CAGR of 6.62% during the forecast period, while healthcare initiatives and government programs in India will enable the market in the country to expand at a CAGR of 6.46%.\n<\/p>\n

\nCompanies Covered<\/strong>\n<\/p>\n